Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Comparing a bioactive bulk-fill layer plus microhybrid versus microhybrid alone for Class II back-tooth restorations

Official title: Clinical Performance of a Bioactive Bulk-Fill Composite in Class II Restorations: A Prospective Split-Mouth Study

Run by Bezmialem Vakif University · NCT07547904 · Data updated 2026-11-12

This study will test whether placing a bioactive bulk-fill layer under a standard microhybrid filling leads to better fit, retention, and less staining for adults who need two similar Class II back-tooth restorations.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment34 (estimated)
SponsorBezmialem Vakif University
Academic / other
Locations1 site (Istanbul)
StatusRecruiting
StartedFebruary 5, 2026
Main results expectedJune 30, 2027
Study endsAugust 30, 2027
Registry record updatedApril 23, 2026
Trial IDNCT07547904 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18–50 in good general and oral health who require at least two comparable Class II posterior restorations and can attend follow-up visits and provide informed consent.

Probably not a fit

Patients with systemic diseases affecting oral health, high caries risk or poor oral hygiene, pregnant or lactating women, teeth with pulp involvement or periapical pathology, or those with a known allergy to the study materials are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective split-mouth clinical study in which each participant receives two comparable Class II posterior restorations, allowing direct intra-individual comparison. In the experimental approach, a bioactive bulk-fill composite (Activa BioACTIVE Bulk Flow) is placed at the gingival base and covered with a microhybrid composite (Filtek Z250), while the control restorations are completed entirely with Filtek Z250. Clinical performance will be scored using FDI World Dental Federation criteria at baseline, 6 months, and 12 months, with primary outcomes of marginal adaptation, retention, and overall clinical success and secondary outcomes including surface properties and marginal staining. The trial will be conducted at Bezmialem Vakif University and enrol adults aged 18–50 who need at least two comparable Class II restorations and are in good general and oral health.

Why it matters

Potential benefit: If successful, this approach could lead to longer-lasting posterior fillings with fewer marginal gaps and less staining.

How similar studies have gone: Laboratory studies and limited short-term clinical reports on bioactive bulk-fill materials have shown promising results for marginal sealing and resistance to staining, but robust long-term clinical evidence is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged between 18 and 50 years
* Patients requiring at least two comparable Class II restorations in posterior teeth
* Good general and oral health
* Ability to provide informed consent

Exclusion Criteria:

* Patients with systemic diseases affecting oral health
* Pregnant or lactating women
* Poor oral hygiene or high caries risk
* Teeth with pulp involvement or periapical pathology
* History of allergy to dental materials used in the study

Where it's running

  • Bezmialem Vakif University
    Istanbul, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.